ArticleAesthetic plastic surgery2026
Factors Associated with the Severity of Female Pattern Hair Loss: A Retrospective Study.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFemale pattern hair loss (FPHL) has a severe impact on physical and mental well-being. The aim of this study is to assess factors associated with the severity of FPHL.
methodsThis retrospective study included 289 patients with FPHL (150 classified as F1 and 139 as F2/3). Thirteen elements were determined using an Inductively Coupled Plasma Mass Spectrometry method. Univariate and multivariate analyses, propensity score-matched (PSM) models, and restricted cubic spline (RCS) analyses were applied to investigate associations and dose-response relationships between elements, vitamins, hormones and FPHL severity
resultsPatients in the F2/3 group were significantly older than those in the F1 group (P = 0.002) and had a longer duration of FPHL (P < 0.001). Serum levels of selenium (Se), zinc (Zn), vitamin B9, and testosterone were significantly lower in the F2/3 group compared with the F1 group (all P < 0.05). However, multivariate analysis demonstrated that only disease duration remained an independent risk factor for increased FPHL severity (OR 1.123 [95% CI 1.047-1.211]; P = 0.02), which was further validated by RCS analysis. After PSM adjustment of demographic characteristics, no significant differences in elements, vitamins, or hormone levels were observed between the F1 and F2/3 groups.
conclusionsElements, vitamins, and hormones were not predictors of FPHL after adjustment for demographic characteristics. Larger prospective cohort studies are warranted to validate these findings. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41526740What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.